Stay updated with breaking news from Infarction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In patients who had revascularization after an acute MI and had a preserved EF, long-term beta-blocker use showed no benefit compared with no beta-blockers, in REDUCE-AMI. ....
Bempedoic acid and bempedoic–ezetimibe are now indicated to prevent myocardial infarction and cardiovascular procedures in both primary- and secondary-prevention patients regardless of statin use. ....
The threshold of Lp(a) linked to increased risk for cardiovascular events may be different for primary and secondary prevention populations, new data suggested. ....
After a recent myocardial infarction, daily low-dose colchicine reduces the risk for cardiovascular events in patients with type 2 diabetes, a recent study shows. ....